Onychomycosis (Tinea Unguium) Drug Market Size, Key Players and Growth Opportunities Analysis till 2022
The global onychomycosis (Tinea Unguium) market is expected to rise at a substantial CAGR in the years to come. Onychomycosis is an infection that is basically a fungal disease of the nail. It is also known as Tinea Unguium. The person’s toenails and fingernails get affected. Proper treatment is being given to the patient based on the symptoms. Terbinafine is the most popular medication that is employed for curing the particular infection. Moreover, the medication can also be deployed to treat other forms of illnesses such as pityriasis versicolor, ringworm, and fungal nail infections. It can be consumed via mouth or applied to the skin in the form of a cream or ointment.
The global onychomycosis (Tinea Unguium) market is expected to rise at a substantial CAGR in the years to come. Onychomycosis is an infection that is basically a fungal disease of the nail. It is also known as Tinea Unguium. The person’s toenails and fingernails get affected. Proper treatment is being given to the patient based on the symptoms. Terbinafine is the most popular medication that is employed for curing the particular infection. Moreover, the medication can also be deployed to treat other forms of illnesses such as pityriasis versicolor, ringworm, and fungal nail infections. It can be consumed via mouth or applied to the skin in the form of a cream or ointment.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong><br />
<strong>Market</strong> <strong>Size</strong>, <strong>Key</strong> <strong>Players</strong> <strong>and</strong> <strong>Growth</strong><br />
<strong>Opportunities</strong> <strong>Analysis</strong> <strong>till</strong> <strong>2022</strong><br />
“<strong>Onychomycosis</strong> is an infection that is basically a fungal<br />
disease of the nail. It is also known as <strong>Tinea</strong> <strong>Unguium</strong>. The<br />
person’s toenails <strong>and</strong> fingernails get affected. Proper<br />
treatment is being given to the patient based on the<br />
symptoms. Terbinafine is the most popular medication that is<br />
employed for curing the particular infection.”<br />
The global onychomycosis (<strong>Tinea</strong> <strong>Unguium</strong>) market is expected to rise at a substantial CAGR in the years to come.<br />
<strong>Onychomycosis</strong> is an infection that is basically a fungal disease of the nail. It is also known as <strong>Tinea</strong> <strong>Unguium</strong>. The<br />
person’s toenails <strong>and</strong> fingernails get affected. Proper treatment is being given to the patient based on the symptoms.<br />
Terbinafine is the most popular medication that is employed for curing the particular infection. Moreover, the medication<br />
can also be deployed to treat other forms of illnesses such as pityriasis versicolor, ringworm, <strong>and</strong> fungal nail infections.<br />
It can be consumed via mouth or applied to the skin in the form of a cream or ointment.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/onychomycosis-tinea-unguium-drug-market<br />
Researches <strong>and</strong> studies show that other types of cream or ointment are not as effective as Terbinafine when it comes to<br />
the treatment of nail infections as they may lead to itchiness <strong>and</strong> other side effects. Terbinafine has been recognized as<br />
one of the most proficient medications among all. As far as the working of the medication goes, it works by lessening
the ability of fungi to form sterols. The product is gaining huge recognition across the globe as the dem<strong>and</strong>s <strong>and</strong><br />
applications among the population are rising on a robust rate.<br />
The factors responsible for raising the <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> share may entail robust<br />
industrialization, urbanization, rise in the internet shopping, rising inclinations, rise in the prerequisites, mounting skin<br />
<strong>and</strong> nail infections among adults, rising concerns regarding health, mounting disposable income, constant innovations,<br />
technological advancements, augmentation in the disposable income, increased awareness among the end users, rising<br />
dem<strong>and</strong> from the customers, <strong>and</strong> rise in the investments by the leading investments.<br />
Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> is segmented on the basis of product type as Capsule, Ointment,<br />
Tablet, <strong>and</strong> others. On the basis of type, it can also be segregated as External, <strong>and</strong> Oral. It has been estimated that the<br />
<strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> will display a robust growth in near future due to rising applications<br />
<strong>and</strong> scope across the globe.<br />
<strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> is segmented based on product usage type as External Medicine, Oral<br />
Medication, <strong>and</strong> others. <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> is segmented by end user as Children, The<br />
Aged, The Middle-aged, <strong>and</strong> others. <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> is segmented based on geography<br />
as North America, Southeast Asia, China, Europe, Japan, <strong>and</strong> India.<br />
Among all the geographical regions, North America is lately been recognized as the leader of the market <strong>and</strong> it is<br />
accounting for the largest share in the market, the reason being robust industrialization, urbanization, <strong>and</strong> rising health<br />
issues among the population. On the other h<strong>and</strong>, it is likely that Asia Pacific <strong>and</strong> Europe will soon come up as one of<br />
the promising regions owing to rise in the market growth opportunities in these regions.<br />
The prominent players operating in the <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> are recognized as Pfizer,<br />
Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Galderma pharm, Zhejiang<br />
Deyer, Valeant Pharma, Moberg, <strong>and</strong> Hubei Hengan, TARO, Perrigo, Xiuzheng, <strong>and</strong> Pharmaceutical.<br />
Get a Sample Copy of This Report @<br />
https://www.millioninsights.com/industry-reports/onychomycosis-tinea-unguium-drug-market/request-sample<br />
<strong>Market</strong> Segment<br />
Geographically, this report is segmented into several key Regions, with production, consumption, revenue<br />
(million USD), market share <strong>and</strong> growth rate of <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> in these regions, from<br />
2012 to <strong>2022</strong> (forecast), covering<br />
• North America<br />
• Europe<br />
• China<br />
• Japan
• Southeast Asia<br />
• India<br />
Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> market competition by top manufacturers, with production, price,<br />
revenue (value) <strong>and</strong> market share for each manufacturer; the top players including<br />
• Johnson & Johnson<br />
• GSK<br />
• Novartis<br />
• Pfizer<br />
• Valeant Pharma<br />
• Kaken Pharmaceutical<br />
• Galderma<br />
• Xiuzheng Pharmaceutical<br />
• Letai<br />
• Qilu Pharmaceutical<br />
See More Reports of This Category by Million Insights @<br />
https://www.millioninsights.com/industry/pharmaceuticals<br />
On the basis of product, this report displays the production, revenue, price, market share <strong>and</strong> growth rate of<br />
each type, primarily split into<br />
• Oral Type<br />
• External Use Type<br />
On the basis on the end users/applications, this report focuses on the status <strong>and</strong> outlook for major<br />
applications/end users, consumption (sales), market share <strong>and</strong> growth rate of <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>)<br />
<strong>Drug</strong> for each application, including<br />
• Age under 18<br />
• Age 18-50
• Age above 50<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/onychomycosis-tinea-unguium-drug-market<br />
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.<br />
Our representatives strive to underst<strong>and</strong> diverse client requirements <strong>and</strong> cater to the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9<br />
Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong><br />
Galleria, Model Colony, Shivaji Nagar,<br />
Pune, MH, 411016 India<br />
Phone: 91-20-65300184<br />
Email: sales@millioninsights.com<br />
Visit Our Blog: www.millioninsights.blogspot.com
Change language